Clinical Trials

/Clinical Trials

GIST Updates from the ASCO Annual Meeting 2018

Executive Director, Norman Scherzer, and Real World Evidence Data Scientist, Dr. Yu Wang, of the Life Raft Group recently attended the ASCO (American Society of Clinical Oncologists) 2018 meeting in Chicago. Dr. Wang describes [...]

By |2018-10-29T13:43:20+00:00June 18th, 2018|Clinical Trials, News, Research|

Deciphera Pharmaceuticals Announces the Start of Phase 3 Clinical Trial with DCC-2618 in GIST

On January 4th, 2018 Deciphera Pharmaceuticals, Inc, announced the start of the Phase 3 INVICTUS trial. This randomized trial is for 4th line GIST patients that have failed (or are intolerant) the [...]

By |2018-10-29T13:46:27+00:00January 9th, 2018|Clinical Trials, News|

It’s a Journey: Our Experience on Clinical Trials

By Jennifer Moore, LRG Member I was waiting in line to pick up a new prescription for Gleevec when my husband ran in and told me to forget it. After two surgeries, a year [...]

By |2018-10-29T13:46:42+00:00December 28th, 2017|Clinical Trials, Member Stories, News, Newsletter|

GIST Patient Community Update on BLU-285 Clinical Program

Dr. Anthony Boral, Chief Medical Officer of Blueprint Medicines, provided an update on the clinical development of BLU-285, an investigational medicine being developed for patients with advanced GIST. The presentation included an [...]

By |2018-10-30T09:14:36+00:00July 6th, 2017|Clinical Trials, Webcast|

Loxo Oncology Announces Plans for LOXO-101

In a recent press release, Loxo Oncology announced an update on the status of their TRK (tropomyosin receptor kinase) inhibitor drug, larotrectinib (LOXO-101). Larotrectinib targets the NTRK genes, which encode for the TRK kinases. [...]

By |2018-10-30T09:25:21+00:00December 22nd, 2016|Clinical Trials, News, Research|

Recent Posts

Upcoming Events

  1. GDOL Los Angeles 2019

    February 16, 2019 @ 8:00 AM - 5:00 PM